Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Krishnan R et al. - Acute submacular haemorrhages appear to be a significant adverse event following intravitreal bevacizumab in occult CNV >= 15 mm2. Intravitreal ranibizumab appears to have a significantly lower incidence of postoperative submacular haemorrhage in occult CNV >= 15 mm2. Larger studies are required to identify the most appropriate agent for the treatment of large occult CNV.

Today in Trauma...keeping you current

The pattern of perforating eye injuries in Ireland
Irish Journal of Medical Science, 12/18/09

Thymosin beta 4 in combination with anti-inflammatory agents reverses "second-hand" cigarette smoke-induced impairment of cornea wound healing
Investigative Ophthalmology and Visual Science, 12/18/09

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address